Journal article
The Role of Surfactant Therapy in Nonrespiratory Distress Syndrome Conditions in Neonates
American journal of perinatology, v 33(1), pp 1-8
01 Jan 2016
PMID: 26171600
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
While treatment of respiratory distress syndrome (RDS) with surfactant in premature neonates is well established, evidence for its use in non-RDS conditions, especially in the term neonate, has been less abundant. The last published review on a PubMed search was in 2001. In this review, we comprehensively and critically evaluated the evidence from the literature regarding the use of surfactant in specific non-RDS disorders in neonates. Surfactant administered as a bolus should be considered in the treatment of meconium aspiration syndrome with progressive respiratory failure. While controversial in congenital diaphragmatic hernia, it should be considered in Group B streptococcal pneumonia. As evidence evolves, we anticipate the broader application and more routine use of surfactant therapy for respiratory failure because of causes other than RDS.
Metrics
Details
- Title
- The Role of Surfactant Therapy in Nonrespiratory Distress Syndrome Conditions in Neonates
- Creators
- Amaris Keiser - Yale UniversityVineet Bhandari - Yale University
- Publication Details
- American journal of perinatology, v 33(1), pp 1-8
- Publisher
- Thieme Medical Publishers
- Number of pages
- 8
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- Pediatrics
- Web of Science ID
- WOS:000367556500001
- Scopus ID
- 2-s2.0-84953639347
- Other Identifier
- 991019167593804721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Collaboration types
- Domestic collaboration
- Web of Science research areas
- Obstetrics & Gynecology
- Pediatrics